Antigua and Barbuda vs Chad: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Chad
100.0%
in 2024
Antigua and Barbuda rank
1st
Chad rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Chad
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Chad, a difference of 0.0%.
Across all 6 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 1st and Chad ranks 1st of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 49.2% | 50.8% | Antigua and Barbuda |
| 2020s | 100.0% | 99.0% | 1.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Chad?
- Antigua and Barbuda, at 100.0% against 100.0% in Chad as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Chad?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Chad?
- 6 years are reported by both, from 2010 to 2022.
- How do Antigua and Barbuda and Chad rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Chad ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.